8-KEarnings & ResultsExhibits & Filings

CENTENE CORP 8-K Report, Financial Results (Jul 27, 2021)

Filed July 27, 2021For Securities:CNC

Summary

Centene Corporation (CNC) filed an 8-K on July 27, 2021, primarily to announce its financial results for the second quarter ended June 30, 2021, via an attached press release (Exhibit 99.1). While the filing itself is brief, the core information for investors lies within the details of the Q2 2021 performance and any forward-looking guidance provided in the press release. Investors should pay close attention to revenue, earnings per share (EPS), and any changes or confirmations to the company's full-year outlook. The 8-K serves as a notification that these results have been publicly disclosed. The actual financial performance, operational highlights, and management's commentary are contained within the referenced press release. Key metrics to scrutinize would include the performance across Centene's various business segments, such as its government-sponsored health plans (Medicaid, Medicare), and any updates on its strategic initiatives or integration of recent acquisitions. Understanding these details will be crucial for assessing the company's trajectory and valuation.

Key Highlights

  • 1Centene Corporation filed an 8-K on July 27, 2021, announcing its Q2 2021 financial results.
  • 2The financial results and related commentary are detailed in the attached press release (Exhibit 99.1).
  • 3Investors should review the press release for specific Q2 2021 revenue, EPS, and profitability metrics.
  • 4The filing indicates updates to the company's financial condition and results of operations for the period.
  • 5Information provided is furnished, not filed, meaning it's for disclosure and not subject to certain SEC liability provisions.
  • 6Key investor focus should be on the performance of government-sponsored health plans and any strategic updates.

Frequently Asked Questions

The main purpose of this 8-K filing is to formally announce Centene Corporation's financial results for the second quarter ended June 30, 2021, by including the relevant press release as an exhibit.

The detailed financial results, management commentary, and any forward-looking guidance are contained within the press release, which is included as Exhibit 99.1 to this 8-K filing.

Investors should focus on key metrics such as total revenue, earnings per share (EPS), profitability (net income and margins), performance across different business segments (Medicaid, Medicare, etc.), and any updates to the company's full-year financial guidance.

While the 8-K itself does not contain the guidance, the accompanying press release (Exhibit 99.1) is expected to provide updated financial guidance for the full year and potentially commentary on future business outlook.